Skip to content

Clinical Observation of Ciprofol for Anesthesia Induction

Clinical Observation of Ciprofol for Anesthesia Induction in the Elderly Undergoing Elective Non-cardiac Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05706337
Enrollment
90
Registered
2023-01-31
Start date
2023-02-01
Completion date
2023-12-31
Last updated
2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Hemodynamic Instability, Pain

Keywords

Anesthesia induction, Ciprofol, propofol, Injection pain

Brief summary

To evaluate the effect of ciprofol anesthesia Induction on hemodynamics in elderly patients undergoing elective noncardiac surgery,a prospective, randomized, controlled trial.

Detailed description

90 elderly patients undergoing noncardiac surgery were randomly divided into propofol group and ciprofol group, who were given propofol 1 \ 2mg/kg or ciprofol 0.2-0.5mg/kg during anesthesia induction respectively. Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and BIS values at various time points during anesthesia induction were collected. At the same time, rates of injection pain, muscle fasciculation, arrhythmia, cough and perioperative hepatic and renal functions were compared between the two groups. The primary outcomes were the fluctuations in hemodynamic parameters during induction. The secondary outcome were adverse reactions, BIS values and changes of hepatic and renal functions during induction.

Interventions

DRUGPropofol

Propofol 1-2mg / kg was for anesthesia induction. Propofol is a hypnotic agent that is used as an induction agent and as a maintenance anaesthetic delivered by continuous i.v. infusion or intermittent i.v. bolus.

DRUGCiprofol

Ciprofol 0.2~0.5mg/kg was for anesthesia induction. Ciprofol is an intravenous sedative-hypnotic and a short-acting GABAA receptor agonist. It activates GABAergic neurons by enhancing chloride ion influx. It is used for anesthetic induction and maintenance agents include rapid induction of general anesthesia, rapid return of consciousness, minimal residual effects on the central nervous system and less injection pain.

Sponsors

Xiumei Song
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ASA physical status Ⅰ-Ⅲ 2. Age over 65 years; 3. Body mass index (BMI) 20 \ 30 kg/m2 ; 4. Elective noncardiac surgery;

Exclusion criteria

1. The patient or his/her family refused to participate in the clinical trial; 2. Severe heart, lung, liver or kidney dysfunction; 3. Expected difficult airway, requiring awake tracheal intubation; 4. Those who are allergic to the drugs used in this study; 5. Unsuccessful tracheal intubation twice; 6. Patients with mental illness or impaired consciousness;

Design outcomes

Primary

MeasureTime frameDescription
Hemodynamic changes:Systolic blood pressure (SBP)From the beginning of drug administration to 30 minutes after intubationSystolic blood pressure (SBP) during anesthesia induction
Hemodynamic changes: Diastolic blood pressure(DBP)From the beginning of drug administration to 30 minutes after intubationDiastolic blood pressure(DBP) during anesthesia induction
Hemodynamic changes: Heart rate (HR )From the beginning of drug administration to 30 minutes after intubationHeart rate (HR )during anesthesia induction

Secondary

MeasureTime frameDescription
adverse reactions: injection painanesthesia inductioninjection pain from propofol or ciprofol intravenous injection
adverse reactions: muscle fasciculationanesthesia inductionmuscle fasciculation induced by propofol or ciprofol intravenous induction
Monitoring Depth of Anesthesiaanesthesia inductionBIS values
perioperative hepatic function: Aspartate Aminotransferase ( AST)Before surgery , 1day after operationlevel of Aspartate Aminotransferase ( AST)
perioperative renal function:Blood Urea NitrogenBefore surgery , 1day after operationlevel of Blood Urea Nitrogen(BUN)
adverse reactions:arrhythmiaanesthesia inductionarrhythmia induced by propofol or ciprofol intravenous induction
perioperative hepatic function: Alanine Aminotransferase ( ALT)Before surgery , 1day after operationlevel of Alanine Aminotransferase ( ALT)
perioperative renal function: creatineBefore surgery , 1day after operationlevel of creatine

Contacts

Primary ContactXiumei Song, Doctor
ssm801117@163.com+8613969050425
Backup ContactJinwan Guo, Master
guojinwan2010@163.com_+8617686830961

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026